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Elizabethkingia anophelis 
bacteremia is associated with 
clinically significant infections and 
high mortality
Susanna K. P. Lau1,2,3,4, Wang-Ngai Chow1, Chuen-Hing Foo1, Shirly O. T. Curreem1, 
George Chi-Shing Lo1, Jade L. L. Teng1, Jonathan H. K. Chen1, Ricky H. Y. Ng5, Alan K. L. Wu6, 
Ingrid Y. Y. Cheung7, Sandy K. Y. Chau5, David C. Lung8, Rodney A. Lee6, Cindy W. S. Tse7, 
Kitty S. C. Fung5, Tak-Lun Que8 & Patrick C. Y. Woo1,2,3,4
Unlike Elizabethkingia meningoseptica, the clinical importance of E. anophelis is poorly understood. 
We determined the clinical and molecular epidemiology of bacteremia caused by Elizabethkingia-
like species from five regional hospitals in Hong Kong. Among 45 episodes of Elizabethkingia-like 
bacteremia, 21 were caused by Elizabethkingia, including 17 E. anophelis, three E. meningoseptica and 
one E. miricola; while 24 were caused by other diverse genera/species, as determined by 16S rRNA 
gene sequencing. Of the 17 cases of E. anophelis bacteremia, 15 (88%) were clinically significant. The 
most common diagnosis was pneumonia (n = 5), followed by catheter-related bacteremia (n = 4), 
neonatal meningitis (n = 3), nosocomial bacteremia (n = 2) and neutropenic fever (n = 1). E. anophelis 
bacteremia was commonly associated with complications and carried 23.5% mortality. In contrast, of 
the 24 episodes of bacteremia due to non-Elizabethkingia species, 16 (67%) were clinically insignificant. 
Compared to non-Elizabethkingia bacteremia, Elizabethkingia bacteremia was associated with 
more clinically significant infections (P < 0.01) and positive cultures from other sites (P < 0.01), less 
polymicrobial bacteremia (P < 0.01), and higher complication (P < 0.05) and mortality (P < 0.05) rates. 
Elizabethkingia bacteremia is predominantly caused by E. anophelis instead of E. meningoseptica. 
Elizabethkingia bacteremia, especially due to E. anophelis, carries significant morbidity and mortality, 
and should be considered clinically significant unless proven otherwise.
The genus Elizabethkingia comprises aerobic, non-fermenting, non-motile and non-spore-forming gram-negative 
rods that were previously named Flavobacterium or belonged to CDC group IIa and later reclassified as 
Chryseobacterium in 19941. In 2005, Chryseobacterium meningosepticum and C. miricola were transferred to a 
new genus, Elizabethkingia, on the basis of combined phenotypic and phylogenetic characteristics2. The genus 
comprises three medically important species, Elizabethkingia anophelis, E. meningoseptica and E. miricola. A 
novel species, E. endophytica, isolated from sweet corn, was also recently proposed3. E. meningoseptica, previously 
named Flavobacterium meningosepticum or C. meningosepticum, is the best known species among the genus. E. 
meningoseptica is a causative agent of nosocomial infections especially in immunocompromised patients, as well 
as neonatal meningitis and sepsis4. Besides soil, fresh water and plants, the bacterium can be found in hospital 
environments and may contaminate flushing solutions and medical devices5. Infections caused by E. menin-
goseptica can be difficult to treat and carry high mortalities, which may be partly explained by their intrinsic 
multidrug resistance towards commonly used antibiotics such as β -lactams and aminoglycosides6. Therefore, 
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accurate diagnosis is important to guide appropriate antibiotic regimens which often consist of a combination of 
ciprofloxacin or rifampicin with piperacillin-tazobactam or vancomycin.
In contrast to E. meningoseptica, the epidemiology and pathogenicity of E. anophelis and E. miricola were less 
well understood. E. miricola, originally named C. miricola when first isolated from condensed water obtained 
from the Russian space station, Mir, only rarely causes nosocomial infections in human7,8. On the other hand, 
E. anophelis was first isolated from midgut of the mosquito Anopheles gambiae in 20119. Soon after its discovery, 
it was reported to cause neonatal meningitis in the Central African Republic and a nosocomial outbreak in an 
intensive-care unit in Singapore10,11. The first discovery of E. anophelis from mosquito gut has raised suspicion 
on mosquitoes as the source of neonatal meningitis cases in Africa10. However, our recent report on E. anophelis 
meningitis in two neonates and chorioamnionitis in a neonate’s mother in Hong Kong suggested that mosquitoes 
were unlikely the vehicles of transmission12. Since the transmission route was initially obscure, draft genome 
sequencing was performed and showed evidence for perinatal vertical transmission from a mother to her neo-
nate12. The ultimate resolution power of genome sequencing also enabled species confirmation and discrimina-
tion from the phenotypically similar species, E. meningoseptica12.
Since E. anophelis was commonly misidentified as E. meningoseptica in previous reports10–13, we hypothesize 
that many previously described E. meningoseptica isolates were actually E. anophelis and that E. anophelis may 
account for a significant proportion of Elizabethkingia infections. To better understand the epidemiology and 
clinical disease spectrum of E. anophelis and Elizabethkingia as a whole, we determined the clinical and molecular 
epidemiology of bacteremia caused by Elizabethkingia-like species from five regional hospitals in Hong Kong. All 
bacteremia episodes caused by Elizabethkingia-like species identified by conventional phenotypic tests from 2004 
to 2013 during the study period were included. For the 45 episodes of Elizabethkingia-like bacteremia identified, 
16S rRNA gene sequencing was performed for species identification and clinical characteristics and outcomes 
were analyzed.
Results
Identification of Elizabethkingia-like bacteremia by 16S rRNA gene sequencing. Twenty-one 
of the 45 episodes of Elizabethkingia-like bacteremia were caused by Elizabethkingia, while 24 episodes were 
caused by diverse genera/species including Chryseobacterium (n = 15), Flavobacterium (n = 1), Planobacterium 
(n = 6), Sphingobacterium (n = 1) and Weeksella-like species (n = 1) according to 16S rRNA gene analysis (Fig. 1 
and see Supplementary Table 1). Of the 21 episodes of Elizabethkingia bacteremia, 17 were caused by E. anophelis 
(99.0–99.9% nucleotide identity to E. anophelis type strain R26T), three by E. meningoseptica (99.4–99.8% nucleo-
tide identity to E. meningoseptica type strain ATCC 13253T) and one by E. miricola (99.5% nucleotide identity to 
E. miricola type strain LMG 22470T).
Among the 24 episodes of non-Elizabethkingia bacteremia, 15 were caused by Chryseobacterium species, 
among which two (C13 and C15) represented two potentially novel Chryseobacterium species (≤ 98.4% nucleo-
tide identity to existing Chryseobacterium species). One episode was caused by another potentially novel species 
most closely related to Weeksella (91.9% nucleotide identity to Weeksella virosa DSM 16922T). The other eight 
Characteristics
Number of patients (%)
P-valuec
Elizabethkingia bac-
teremia (n = 21)
Non-Elizabethkingia 
bacteremia (n = 24)
Sex (male:female) 11:10 13:11 0.90
Underlying diseases 19 (90.5) 24 (100) 0.12
Hospital- vs community-acquireda 15:4 7:1 0.60
Diagnosisb
 Biliary tract infection 2 (9.5) 0 (0) 0.12
 Catheter-related bacteremia 5 (23.8) 1 (4.2) 0.05
 Community-acquired pneumonia 3 (14.3) 0 (0) 0.06
 Neonatal meningitis 3 (14.3) 0 (0) 0.06
 Neutropenic fever 1 (4.8) 2 (8.3) 0.63
 Nosocomial bacteremia 3 (14.3) 5 (20.8) 0.57
 Nosocomial pneumonia 2 (9.5) 0 (0) 0.12
 Primary bacteremia 0 (0) 1 (4.2) 0.34
 Pseudobacteremia 2 (9.5) 16 (76.1) 0.00009
> 1 positive blood cultures 3 (14.3) 1 (4.2) 0.23
Polymicrobial bacteremia 0 (0) 10 (41.7) 0.0008
Positive cultures from other sites 8 (38.1) 1 (4.2) 0.005
Complications 7 (33.3) 1 (4.2) 0.01
Attributable mortality 4 (19.0) 0 (0) 0.025
Table 1. Characteristics of the 45 patients with bacteremia caused Elizabethkingia-like organisms  
aexcluding pseudobacteremia. bThe percentages add up to more than 100% because some patients have more 
than one diagnosis. cby Chi-square test.
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episodes were caused by Planobacterium (n = 6), Flavobacterium (n = 1) and Sphingobacterium (n = 1) species 
respectively.
Clinical characteristics of patients with Elizabethkingia-like bacteremia. The clinical charac-
teristics of the 45 episodes of Elizabethkingia-like bacteremia were summarized in Tables 1–3. Of the 17 epi-
sodes of E. anophelis bacteremia, the male:female ratio was 11:6, with a median age of 58 years (range, 1 day to 
104 years) (Table 2). Most patients had underlying diseases. Except two patients with pseudobacteremia, most 
cases were associated with clinically significant bacteremia, with 12 cases being hospital-acquired and three 
community-acquired. The most common diagnosis was pneumonia (n = 5), followed by catheter-related bacter-
emia (n = 4), neonatal meningitis (n = 3), nosocomial bacteremia (n = 2) and neutropenic fever (n = 1). Among 
the five cases of pneumonia, three were community-acquired, including one in a 51-year-old previously healthy 
man (case EA10). All three cases of neonatal meningitis were hospital-acquired. Details of two (HKU36 and 
HKU38) of the three neonatal meningitis cases have been reported previously12. They were included because 
they fell into the inclusion criteria during the study period. The source of E. anophelis in the two cases of noso-
comial bacteremia and one case of neutropenic fever was obscure, although severe mucositis was present in 
the latter. Three of the 17 patients had multiple positive blood cultures. E. anophelis was concomitantly isolated 
from other body sites in seven patients, including cerebrospinal fluid (n = 3), respiratory samples (n = 3) and 
catheter tip (n = 1). Most patients survived, but four patients died despite appropriate antibiotics given in two of 
the four patients. Complications as a result of E. anophelis bacteremia included acute pulmonary edema, conges-
tive heart failure, multi-organ failure, disseminated intravascular coagulation, septic shock, haematemesis, acute 
renal failure, metabolic acidosis and intraventricular haemorrhage. Various antibiotic regimens as single drug or 
combinations were used for empirical or definitive treatment, including quinolones, penicillins, cephalosporins, 
Figure 1. Phylogenetic tree showing the relationship of the 45 Elizabethkingia-like blood culture isolates 
to related bacterial species using 16S rRNA gene sequence analysis. The tree was constructed by maximum 
likelihood method using General Time Reversible model and Escherichia coli (CP010304) as the root. A total of 
1325 nucleotide positions were included in the analysis. Bootstrap values were calculated from 1000 replicates. 
The scale bar indicates the number of substitutions per site. Names and accession numbers are given as cited in 
GenBank database.
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Case/
strain no. Sex Age Underlying diseases Diagnosis
Community-  
or hospital-acquired
No. of positive blood 
cultures  
(concomitant isolates)
Other culture- 
positive 
specimens Antibiotic treatment
Complications/out-
comee
E. anophelis
EA1 M 54 DM, hyperlipidemia, ischem-ic cardiomyopathy
Nosocomial 
pneumonia HA 1 None Piperacillin-tazobactam
Acute pulmonary ede-
ma, CHF, survived
EA2 M 65
HT, DM, CAD, PVD, RAS, 
hyperlipidemia, carotid 
stenosis
Pseudobac-
teremia NA 1 None
Cloxaciillin and levoflox-
acin, then amoxicil-
lin-clavulanate
Survived
EA3 F 1m Prematurity, twin, RDS, PDA
Cathe-
ter-related 
bacteremia
HA 3 None Vancomycin, cefopera-zone-sulbactam
Multi-organ failure, 
died
EA4 F 8d Imperforated anus, rectovag-inal fistula
Neonatal 
meningitis HA 2 CSF
Vancomycin and 
rifampicin Survived
EA5 M 65 COPD, CAD, CHF, AF, CRHD, right hip AVN
Communi-
ty-acquired 
pneumonia
CA 1 Sputum Ciprofloxacin Survived
EA6 M 37 Dilated cardiomyopathy, CAD
Nosocomial 
bacteremia HA 1 None Ciprofloxacin DIC, survived
EA7 F 64 HT, hyperlipidemia, stage 4 DLBC lymphoma
Neutro-
penic 
fever, severe 
mucositis
HA 2 None Meropenem Septic shock, haemate-mesis, died
EA8 M 68 HT, CRF, AAA Nosocomial bacteremia HA 1
Tracheal 
aspirate
Levofloxacin and van-
comycin
Acute renal failure, 
died
EA9 M 73 CA hypopharynx, CA ampul-la of Vater
Pseudobac-
teremia NA 1 None Cefuroxime Survived
EA10 M 51 None
Communi-
ty-acquired 
pneumonia
CA 1 Sputum Ampicillin-sulbactam, then ciprofloxacin Survived
EA11 F 104 HT, CAD, CVA, nephrotic syndrome
Communi-
ty-acquired 
pneumonia
CA 1 None Amoxicillin-clavulanate Died
EA12 M 59 obesity, DM, CAD
Cathe-
ter-related 
bacteremia, 
drip site 
cellulitis
HA 1 None Levofloxacin Survived
EA13 F 35 Epilepsy, HT, ESRF on HD
Cathe-
ter-related 
bacteremia
HA 1 None Levofloxacin Survived
EA14 M 58 CRHD with AVR, ESRF on HD
Cathe-
ter-related 
bacteremia
HA 1 Catheter tip Piperacillin-tazobactam, then levofloxacin Septic shock, survived
EA15 M 88 COPD, old PTB
Nosocomial 
(aspiration) 
pneumonia
HA 1 None Levofloxacin Survived
HKU36 M 21d None Neonatal meningitis HA 1 CSF
Vancomycin, piperacillin 
and rifampicin Survived
HKU38 F 1d Apnea of prematurity Neonatal meningitis HA 1 CSF
Vancomycin, pipera-
cillin-tazobactam and 
rifampicin
metabolic acidosis, 
IVH, survived
E. meningoseptica
EME1 M 51 Asthma, HT, scoliosis, MSSA infective spondylitis
Nosocomial 
bacteremia HA 1 None Ticarcillin-clavulanate Survived
EME2 M 52
Biliary pancreatitis, RPC, 
cholecystectomy, cirrhosis 
with biliary stent
Post-chol-
angiogram 
acute 
cholangitis
HA 1 None Levofloxacin and metro-nidazole Survived
EME3 F 89 HT, AF, painless obstructive jaundice on palliative stenting
Biliary 
sepsis CA 1 None Levofloxacin Survived
E. miricola
EMI1 M 54 DM, hyperlipidemia, ischem-ic cardiomyopathy
Cathe-
ter-related 
bacteremia
HA 1 CVP catheter Levofloxacin Survived
Table 2.  Clinical characteristics of patients with Elizabethkingia bacteremia. aAAA, abdominal aortic 
aneurysm; AF, atrial fibrillation; AVN, avascular necrosis; AVR, atrial valve replacement; CA, carcinoma; CA, 
community-acquired; CAD, coronary artery disease; CHF, congestive heart failure; COPD; chronic obstructive 
pulmonary disease; CRF, chronic renal failure; CRHD, chronic rheumatic heart disease; CSF, cerebrospinal 
fluid; CVA, cerebrovascular accident; CVP, central venous pressure; DIC, disseminated intravascular 
coagulation; DLBC, diffuse large B cell; DM, diabetes mellitus; ESRF, end-stage renal failure; HA, hospital-
acquired; HD, hemodialysis; HT, hypertension; IVH, intraventricular hemorrhage; MSSA, methicillin-sensitive 
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carbapenems, vancomycin and rifampicin. Removal of catheter was often required in catheter-related bacteremia 
cases in addition to antibiotic treatment.
All the four patients with E. meningoseptica or E. miricola bacteremia also had underlying disease and clini-
cally significant infections (Table 2). Two patients with E. meningoseptica bacteremia had biliary tract infections, 
while one had nosocomial bacteremia. Interestingly, the only episode of E. miricola bacteremia (case EMI1) was 
detected in the same patient with E. anophelis nosocomial pneumonia (case EA1) which occurred more than 
one month previously during the same admission and was complicated by heart failure and acute pulmonary 
edema requiring intubation and inotropes. Five weeks after successful treatment with piperacillin-tazobactam, 
the patient developed another episode of bacteremia caused by E. miricola which was also isolated from central 
venous catheter. The patient recovered with levofloxacin and catheter removal.
In contrast, 16 of the 24 patients with bacteremia due to non-Elizabethkingia species had pseudobac-
teremia (Table 3). The other eight patients were diagnosed to have nosocomial bacteremia (three cases), 
transfusion-related bacteremia (two cases), catheter-related bacteremia (one case), neutropenic fever (one case) 
and sepsis (one case). Except for a case of community-acquired sepsis in a 90-year-old man (case P1), all other 
cases were hospital-acquired. Only one episode of catheter-related bacteremia was complicated by septic shock, 
where C. arthrosphaerae was isolated from six blood cultures. All the eight patients survived.
Comparison between Elizabethkingia and non-Elizabethkingia cases showed that clinically significant infec-
tions were more common in patients with Elizabethkingia bacteremia than those with non-Elizabethkingia bac-
teremia (i.e. fewer pseudobacteremia cases were observed) (P < 0.01). Moreover, patients with Elizabethkingia 
bacteremia had more positive cultures from other sites (P < 0.05) and lower incidence of polymicrobial bacter-
emia (P < 0.01). They also showed higher complication (P < 0.05) and mortality (P < 0.05) rates than those with 
with non-Elizabethkingia bacteremia (Table 1).
Microbiological characteristics of Elizabethkingia isolates. All the 21 Elizabethkingia isolates were 
non-motile, oxidase-positive, catalase-positive, indole-positive, non-glucose-fermenting, Gram-negative bacilli. 
Growth on MacConkey agar, citrate utilization, urea hydrolysis and fermentation of cellobiose and melibiose fer-
mentation were variable. All 21 isolates were identified as E. meningoseptica by Vitek 2 GNI system with 91–99% 
confidence. All 21 isolates were susceptible to ciprofloxacin, cefoperazone-sulbactam and vancomycin, but were 
resistant or intermediate-resistant to imipenem, amikacin, gentamicin and tobramycin. Susceptibilities to ceftazi-
dime, piperacillin, rifampicin and cotrimoxazole were variable (see Supplementary Table 2).
MALDI-TOF MS using Reference Library Biotyper v3.1.2.0 (Bruker Daltonik, Germany) failed to identify 
the 17 E. anophelis isolates (10 misidentified as E. meningoseptica with score 2.073 to 2.403, two identified as 
Elizabethkingia species with score 1.952–1.971 and five unidentified with score 1.32 to 1.42 to E. meningoseptica). 
When the database was expanded with inclusion of mass spectra from seven E. anophelis isolates, all the other 10 
E. anophelis isolates were correctly identified as E. anophelis with score 2.321 to 2.634. The three E. meningoseptica 
and one E. miricola strains were correctly identified by the Bruker reference library (see Supplementary Table 2). 
Hierarchical cluster analysis showed that the protein mass spectra of E. anophelis and E. miricola were clustered 
together but formed a distinct branch from E. meningoseptica (Fig. 2).
PFGE typing of E. anophelis. To determine the genetic relatedness of the 17 E. anophelis strains isolated 
from five different hospitals, PFGE was performed using the bacterial genomic and DNA restriction endonu-
clease XbaI. In general, the PFGE patterns among the 17 E. anophelis strains were distinct from each other and 
different from that of the type strain R26T. Dendrogram constructed using the PFGE images showed that some 
adjacently clustered strains were isolated from the same hospital (Fig. 3). For example, strains EA2, EA3 and EA4 
were from hospital 5, while strains EA13 and EA15 were from hospital 6. However, no clear epidemiological 
linkage could be identified in terms of time and place of blood culture isolation. Specifically, strains EA2, EA3 
and EA4 were isolated from different years. Strains EA13 and EA15 were isolated four months apart and the two 
patients were hospitalized in different wards of hospital 6.
Discussion
E. anophelis bacteremia should be considered clinically significant unless proven otherwise and should prompt 
appropriate antibiotic therapy. In contrast to the traditional belief that E. meningoseptica was the most important 
Elizabethkingia species associated with bacteremia, the present study showed that the majority of Elizabethkingia 
bacteremia cases were caused by E. anophelis. In particular, neonatal meningitis was associated exclusively with 
E. anophelis in this study. In the present series, E. anophelis bacteremia mainly occurred in neonates or adults with 
underlying medical illnesses, and was most commonly associated with pneumonia and hospital-acquired infec-
tions such as catheter-related bacteremia and neonatal meningitis. Notably, community-acquired pneumonia 
occurred in three patients including a healthy middle-aged adult, where the infective source remained obscure. 
Apart from the two previous reported cases of neonatal meningitis (HKU36 and HKU38) which were most likely 
acquired from maternal-to-infant transmission based on comparative genomics12, no obvious epidemiological 
linkage or genetic relatedness was identified among the other cases. Nevertheless, some potentially genetically 
related strains upon PFGE analysis may have circulated in the same hospital. Further studies should be performed 
to better understand the disease spectrum and transmission routes of E. anophelis.
Staphylococcus aureus; NA, not applicable; PDA, patent ductus arteriosus; PTB, pulmonary tuberculosis; PVD, 
peripheral vascular disease; RAS, renal artery stenosis; RDS, respiratory distress syndrome; RPC, recurrent 
pyogenic cholangitis.
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Case/ 
strain no. Sex Age Underlying diseases Diagnosis
Community- or 
hospital-acquired
No. of positive blood 
cultures (concomitant 
isolates)
Other cul-
ture-positive 
specimens
Treatment + removal of 
catheter
Complications + 
outcome
Potentially novel Chryseobacterium species
C13 M 64 Metastatic pancreatic carcino-ma, sepsis
Postmortem 
pseudobac-
teremia
NA 1 None NA Died (non-attribut-able)
C15 M 68 Head injury Pseudobac-teremia NA
1 (Acinetobacter sp., 
Enterococcus faecium) No Amoxicillin-clavulanate Survived
Chryseobacterium arthrosphaerae
C1 M 82 HT, gout, BPH, bilateral hy-dronephrosis and hydroureter
Nosocomial 
bacteremia HA 1 None
Piperacillin-tazobactam, 
then levofloxacin Survived
C2 F 48 Stage IV DLBC lymphoma
Cathe-
ter-related 
bacteremia, 
neutropenic 
fever
HA
6 (Klebsiella pneumo-
niae, Acinetobacter 
baumanii)
Central 
catheter
Imipenem-cilastatin and 
amikacin Septic shock, survived
C9 M 56 COPD, pneumothorax Nosocomial bacteremia HA 1 None
Ticarcillin-clavulanate, 
levofloxacin Survived
Chryseobacterium gallinarum
C14 M 1 Cow milk allergy Nosocomial bacteremia HA 1 None Piperacillin-tazobactam Survived
Chryseobacterium hominis
C8 F 76 DM, HT, CVA, CHF, AAA, PVD, hyperlipidemia
Pseudobac-
teremia NA 1 None None Survived
C12 F 51 AML Neutropen-ic fever HA 1 (Moraxella sp.) None
Piperacillin-tazobactam, 
vancomycin Survived
Chryseobacterium indologenes
C3 F 58 Hyperlipidemia, IgA ne-phropathy, Multiple myeloma
Pseudobac-
teremia NA
1 (Stenotrophomonas 
maltophila, Com-
mamonas sp,, Ralstonia 
sp.)
None Levofloxacin, piperacil-lin-tazobactam Survived
C4 F 49
DM, CRF, bilateral hydro-
nephrosis, perinephric and 
psoas abscess
Pseudobac-
teremia NA
1 (Enterococcus 
facaelis, A. baumanii, 
Streptococcus mitis)
None Cefuroxime, ampicillin, levofloxacin Survived
C5 M 78 HT, gout, CA caecum with metastases, thyroidectomy
Pseudobac-
teremia NA 1 (A. baumanii) None
Amoxicillin-clavulanate, 
ciprofloxacin Survived
C6 F 57 CA rectum, mania, small bowel obstruction
Pseudobac-
teremia NA
1 (E. facaelis, A. 
baumanii) None Amoxicillin-clavulanate Survived
C7 M 84 HT, AF,CRHD, CVA, gout, BPH COPD
Pseudobac-
teremia NA 1 None Amoxicillin-clavulanate Survived
C10 F 56 Acute encephalopathy, aspira-tion pneumonia, sepsis
Postmortem 
pseudobac-
teremia
NA
1 (Pseuodmonas puti-
da, Bacillus sp., CNS, 
MSSA, non-hemolytic 
Streptococcus)
None NA Died (non-attributi-ble)
Chryseobacterium taihuense
C11 M 85 DM, DU, BPH Pseudobac-teremia NA 1 None Amoxicillin-clavulanate Survived
Flavobacterium lindanitolerans
F1 F 30 SLE, lupus nephritis
Nosocomial 
(post-trans-
fusion) 
bacteremia
HA 1(Bacillus sp.) None Levofloxacin Survived
Planobacterium taklimakanense
P1 M 90 CAD, COPD, DM, BPH Primary bacteremia CA 1 None Ceftriaxone Survived
P2 M 1d RDS, congenital pneumonia Pseudobac-teremia NA 1 None Penicillin and netilmicin Survived
P3 F 99 COPD, CVA, intertrochanter-ic fracture
Pseudobac-
teremia NA 1 None Amoxicillin-clavulanate Survived
P4 M 56 COPD, BPH, PTB Pseudobac-teremia NA 1 None Levofloxacin Survived
P5 M 52 NPC, thyroidectomy, hypo-thyroidism
Nosocomial 
(post-trans-
fusion) 
bacteremia
HA 1 None Piperacillin-tazobactam Survived
P6 F 1m Sepsis, hypoglycemia Pseudobac-teremia NA 1 None Cefotaxime Survived
Continued
www.nature.com/scientificreports/
7Scientific RepoRts | 6:26045 | DOI: 10.1038/srep26045
E. anophelis bacteremia carries significant morbidity and mortality. Various complications were observed and 
four patients died, giving a mortality rate of 23.5%. This is in line with previous reports of E. anophelis neonatal 
meningitis being associated with poor outcomes10. Nevertheless, all the three present cases of neonatal meningitis 
were cured with early use of appropriate antibiotics12. Although E. anophelis usually confers resistance to multiple 
antibiotics such as ceftazidime, imipenem and aminoglycosides12, all the 17 isolates were susceptible to cipro-
floxacin, cefoperazone-sulbactam and vancomycin, which should be considered in empirical treatment while 
awaiting susceptibility results. In cases of catheter-related bacteremia, infected catheters should be removed in 
addition to antibiotic treatment. Future prospective studies with population-based data should be performed to 
determine the prevalence or incidence of E. anophelis bacteremia.
E. meningoseptica and E. miricola appeared to be much less prevalent than E. anophelis, although similar 
studies in other countries are required to more accurately assess their relative importance. Similar to E. anophelis, 
E. meningoseptica and E. miricola bacteremia were associated with clinically significant infections. Besides one 
case of E. meningoseptica nosocomial bacteremia and one case of E. miricola catheter-related bacteremia, biliary 
tract infections were also noted in two cases of E. meningoseptica bacteremia. It remains to be determined if 
E. meningoseptica may have the propensity to cause biliary tract infections among the genus. Given their similar 
antibiotic susceptibility profiles to that of E. anophelis, ciprofloxacin, cefoperazone-sulbactam and vancomycin 
should also be included in treatment regimens for E. meningoseptica and E. miricola bacteremia.
In contrast to Elizabethkingia species, isolation of non-Elizabethkingia species from blood cultures should 
raise suspicion of their clinical significance. In this study, non-Elizabethkingia bacteremia is associated with 
higher incidence of pseudobacteremia and polymicrobial bacteremia than Elizabethkiniga bacteremia. In par-
ticular, all six isolates of C. indologenes and the three potentially novel species were associated with pseudobacte-
remia. Bacteremia caused by non-Elizabethkingia species is also associated with lower incidence of complications 
and mortality than Elizabethkingia bacteremia, suggesting that these bacterial species may be less virulent than 
Elizabethkingia. Moreover, these environmental, non-Elizabethkingia bacterial species may contaminate blood 
cultures when aseptic techniques during blood taking are breached. Careful clinical assessment is required to 
determine the clinical significance and the need for antibiotics when these bacteria are isolated from blood 
cultures.
Although the two E. anophelis strains, HKU36 and EA14, are phylogenetically genetically close to E. endo-
phytica strain JM-87T, they should belong to E. anophelis instead of E. endophytica or a novel species. The two 
strains possessed 99.9% nucleotide identities to both the newly proposed species, E. endophytica strain JM-87T 
and E. anophelis R26T in their 16S rRNA gene sequences. Although strain JM-87T was reported to possess 
51–52% similarities to E. anophelis R26T by DNA-DNA hybridization3, our previous study showed that the draft 
genome of strain HKU36 possessed 78.3% nucleotide identity to the genome of E. anophelis R26T by estimation of 
intergenomic distance12. Given the close relatedness of strains HKU36, EA14 and JM-87T in their 16S rRNA genes 
(Fig. 1), it is likely that the genome sequences of strain JM-87T and EA14 may also possess > 70% identity to that 
of E. anophelis R26T. Since genome-based comparison can offer ultimate resolution for species delineation which 
is superior to traditional DNA-DNA hybridization methods, genome sequencing of strain JM-87T and related 
strains such as EA14 should be performed to more accurately define their taxonomic positions.
The present results confirmed our suspicion that E. anophelis was a previously under-reported bacterium 
which can be easily misidentified as E. meningoseptica12. Although E. anophelis was first discovered from mos-
quito gut10, we previously showed that maternal chorioamnionitis, instead of mosquitoes, was more likely the 
source of neonatal meningitis12. Similarly, mosquitoes are unlikely the route of transmission in other E. anophelis 
infections. We speculate that contaminated environments, such as infected catheters, are the source of infection 
in most cases, as in the case of previously described “E. meningoseptica” infections. Given their similar pheno-
typic characteristics, E. anophelis isolates from previous reports were often mistaken as E. meningoseptica ini-
tially10–12,14. Phenotypic tests, such as acid production from cellobiose and citrate utilization, previously reported 
as potentially useful for species discrimination12, were unlikely to be reliable. In our previous study, the three E. 
Case/ 
strain no. Sex Age Underlying diseases Diagnosis
Community- or 
hospital-acquired
No. of positive blood 
cultures (concomitant 
isolates)
Other cul-
ture-positive 
specimens
Treatment + removal of 
catheter
Complications + 
outcome
Sphingobacterium daejeonense
S1 M 94
COPD, cor pulmonale, BPH, 
gout, Shy-Drager syndrome, 
CAD
Pseudobac-
teremia NA 1 (K. pneumoniae) None Cotrimoxazole Survived
Potentially novel Weeksella-related species
W1 F 18d RSV pneumonia Pseudobac-teremia NA 1 None
Ampicillin, netilmicin 
and erythromycin Survived
Table 3. Clinical characteristics of patients with non-Elizabethkingia bacteremia. aAAA, abdominal 
aortic aneurysm; AF, atrial fibrillation; AML, acute myeloid leukemia; BPH, benign prostatic hyperplasia; 
CA, carcinoma; CA, community-acquired; CAD, coronary artery disease; CHF, congestive heart failure; CNS, 
coagulase-negative Staphylococcus; COPD; chronic obstructive pulmonary disease; CRF, chronic renal failure; 
CRHD, chronic rheumatic heart disease; CVA, cerebrovascular accident; DLBC, diffuse large B cell; DM, 
diabetes mellitus; DU, Duodenal ulcer; HA, hospital-acquired; HT, hypertension; MSSA, methicillin-sensitive 
Staphylococcus aureus; NA, not applicable; NPC, nasopharyngeal carcinoma; PTB, pulmonary tuberculosis; 
PVD, peripheral vascular disease; RDS, respiratory distress syndrome; RSV, respiratory syncytial virus; SLE, 
systemic lupus erythematosus.
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anophelis strains were also initially misidentified as E. meningoseptica even with MALDI-TOF MS, owing to the 
absence of E. anophelis spectra in commercial databases12. The 16S rRNA genes of E. anophelis possessed > 98% 
nucleotide identity to those of E. meningoseptica and E. miricola, which should offer sufficient discriminative 
Figure 2. Results of MALDI-TOF MS identification of the 21 Elizabethkingia strains. In panel (A), 
representative MALDI-TOF MS spectra of the three Elizabethkingia species are shown. In panel (B), 
dendrogram was generated from hierarchical clustering of MALDI-TOF MS spectra of 21 Elizabethkingia 
isolates and reference strains of E. meningoseptica and E. miricola, using ClinProTools 3.0 (Bruker Daltonics, 
Germany). Distances are displayed in relative units.
Figure 3. Pulsed-field gel electrophoresis (PFGE) analysis of the 17 E. anophelis isolates and E. anophelis 
type strain R26T. (lane 1 = EA1, lane 2 = EA2, lane 3 = EA3, lane 4 = EA4, lane 5 = EA5, lane 6 = EA6, lane 
7 = EA7, lane 8 = EA8, lane 9 = EA9, lane 10 = EA10, lane 11 = EA11, lane 12 = EA12, lane 13 = EA13, lane 
14 = EA14, lane 15 = EA15, lane 16 = HKU38, lane 17 = HKU36, lane 18 = R26T, M = lambda marker). In 
Panel (A), PFGE was performed using CHEF Mapper XA system (Bio-Rad) and restriction endonuclease XbaI. 
Results showed that the 17 isolates possessed distinct PFGE patterns. In Panel (B), dendrogram was constructed 
with PFGE data by similarity and clustering analysis using the Dice coefficient (1% tolerance and 0.5% 
optimization) and unweighted pair-group method using average linkages with GelCompar II.
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power12. However, some “E. meningoseptica” strains with 16S rRNA sequences deposited in GenBank, such as 
strains G3-1-08 and 50215,16, should belong to E. anophelis based on phylogenetic analysis12. These “misidentified” 
strains in GenBank may confuse the interpretation of 16S rRNA gene sequencing results and should be recti-
fied12. While E. anophelis can be distinguished from E. meningoseptica by MALDI-TOF MS when the database is 
expanded with mass spectra from E. anophelis strains, E. anophelis and E. miricola appear to be indistinguishable 
from each other. With an expanded database using E. anophelis isolates, MALDI-TOF MS is the method of choice 
for rapid and accurate diagnosis of E. anophelis infections, which is crucial to better understand its epidemiology 
and clinical disease spectrum.
Methods
Ethics statement. The use of blood culture isolates and anonymous clinical data were approved by Institute 
Review Board, The University of Hong Kong/Hospital Authority, Hong Kong (reference UW 04-278 T/600). The 
methods and all experimental protocols were carried out in accordance with the approved guidelines. Since this 
study does not involve experimentation on human subjects or the use of tissue samples from human subjects, 
written informed consent has been waived by our institutional review board.
Settings and Patients. Patients were hospitalized in five regional hospitals located in different areas of 
Hong Kong from 2004 to 2013. To identify potential cases of Elizabethkingia bacteremia, all bacteremia episodes 
caused by oxidase-positive, non-glucose fermenters that were identified as Elizabethkingia, Flavobacterium or 
Chryseobacterium species by conventional phenotypic tests during the study period were included with clini-
cal data analyzed17. Bacteremia was categorized as clinically significant or pseudobacteremia (contamination of 
blood culture) by clinical and laboratory criteria18. The criteria include the patient’s clinical presentation, physical 
examination findings, body temperature at the time of the blood culture, leukocyte and differential cell counts, 
imaging or operative results, histopathological findings, number of positive blood cultures out of the total num-
ber performed, and response to treatment.
Bacterial isolates. Collection of clinical specimens, bacterial cultures and conventional phenotypic iden-
tification were performed according to standard protocols19. Two of the 45 Elizabethkingia-like isolates from 
two neonates (HKU36 and HKU38) have been reported previously12. The same isolate recovered from the same 
patient was counted only once.
16S rRNA gene sequencing for species identification. The 45 blood culture isolates were subject 
to 16S rRNA gene sequencing according to previously published protocols with modifications, using primers 
LPW57 (5′ -AGTTTGATCCTGGCTCAG-3′ ) and LPW58 (5′ -AGGCCCGGGAACGTATTCAC-3′ )12,20. The 
sequences of PCR products were compared to known gene sequences in GenBank by multiple sequence align-
ment using CLUSTAL_W in MEGA version 621. Phylogenetic tree was constructed by maximum likelihood 
method using MEGA version 621.
Statistical analysis. A comparison of characteristics was made between patients with Elizabethkingia and 
non-Elizabethkingia bacteremia using Chi-square test (IBM SPSS Statistics version 19). P < 0.05 was regarded as 
statistically significant.
Phenotypic characterization and matrix-assisted laser-desorption ionization-time-of-flight 
mass-spectrometry (MALDI-TOF MS) of Elizabethkingia isolates. The 21 Elizabethkinigia iso-
lates were characterized by phenotypic tests, Vitek 2 GNI system (bioMérieux, France) and MALDI-TOF MS. 
MALDI-TOF MS was performed by ethanol formic acid extraction method as described previously, using Bruker 
Daltonics microflex LT system with Reference Library Biotyper v3.1.2.0 (Bruker Daltonik, Germany)22,23. Since 
E. anophelis is not included in the Bruker reference, mass spectra generated from seven E. anophelis strains with 
identity confirmed by 16S rRNA gene sequencing were later added to the database. Obtained spectra were subject 
to hierarchical cluster analysis as described previously24. Antibiotic susceptibility testing was performed by Kirby 
Bauer disk diffusion method with results interpreted according to Clinical and Laboratory Standards Institute for 
Staphylococcus aureus (vancomycin) and Pseudomonas aeruginosa (other drugs), because of the lack of interpre-
tative criteria for Elizabethkingia25.
Pulsed-field gel electrophoresis (PFGE). The 17 E. anophelis isolates were characterized by PFGE using 
CHEF Mapper XA system (Bio-Rad, CA, USA) and restriction endonuclease XbaI as described previously12,26. 
After PFGE, the gel was stained with ethidium bromide (1 μ g/ml) for 30 minutes and the patterns of the genomic 
DNA digest were visualized with a UV transilluminator. Digital images were stored electronically as TIFF files 
and analyzed visually and with GelCompar II (version 3.0; Applied Maths, Kortrijk, Belgium), and represented 
by UPGMA method.
Nucleotide sequence accession number. The 16S rRNA gene sequences of the 45 blood culture isolates 
have been deposited in the GenBank sequence database under accession no. KP875383 to KP875427.
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